Nureca Ltd - 543264 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal Goyal30-11-2022
30-11-2022
Nureca share price hits 52-week low on bulk deal by promoter Payal Goyal
Shares of digital health and wellness company, Nureca, hit 52-week low at 525 after the promoter sold 55,863 shares at 546 apiece29-11-2022
Nureca Ltd - 543264 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure of Related Party Transactions for the half-year ended September 30, 202226-11-2022
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Cessation
Mr. Nitin R. Bidikar has tendered his resignation as an Independent Director of the Company w.e.f. November 24, 2022, on account of personal reason and other professional commitments.25-11-2022
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Newspaper Publication
copies of the newspaper publication of the Unaudited financial results for the quarter and half year ended September 30, 202212-11-2022
Nureca Ltd - 543264 - Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of Board Meeting held on Novemeber 11, 202211-11-2022
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Change in RTA
On November 2, 2022, the Company ('Nureca Limited') has entered into a tripartite agreement with the previous RTA ('Link lntime India Private limited') and new RTA ('Alankit Assignments Limited').07-11-2022
Nureca Ltd - 543264 - Board Meeting Intimation for Notice Of Board Meeting
Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve the unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2022.04-11-2022
Nureca Ltd - 543264 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Chetna AnandDesignation :- Company Secretary and Compliance Officer14-10-2022
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release titled 'Nureca Limited's subsidiary receives ISO 13485 Certification for Indian medical device facility'.07-10-2022